US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Total Receivables
Zymeworks Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Total Receivables
$19.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Total Receivables
$10.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
43%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Receivables
$15.3m
|
CAGR 3-Years
35%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Receivables
$5.5m
|
CAGR 3-Years
90%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Receivables
$28.9m
|
CAGR 3-Years
189%
|
CAGR 5-Years
135%
|
CAGR 10-Years
76%
|
|
Spectral Medical Inc
TSX:EDT
|
Total Receivables
CA$482k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-3%
|
See Also
What is Zymeworks Inc's Total Receivables?
Total Receivables
19.5m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Total Receivables amounts to 19.5m USD.
What is Zymeworks Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
118%
Over the last year, the Total Receivables growth was -42%. The average annual Total Receivables growth rates for Zymeworks Inc have been 8% over the past three years , 118% over the past five years .